ArticleCancersPublished
Outcomes with Single Tremelimumab Regular Interval Durvalumab (STRIDE) for Unresectable Hepatocellular Carcinoma in the US Veterans Administration
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Philadelphia VA Medical Center, Thomas Jefferson University, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- Cancers
- Published
- Topic
- Clinical care
- Subject terms
- Safety; Survival; Carcinoma; Hepatocellular; Therapeutics
- PubMed ID
- 41976308
- PubMed Central ID
- PMC13072021
- Open access
- Yes, open
- Added to directory
- Source checked